Esther Conde

2.5k total citations
51 papers, 1.5k citations indexed

About

Esther Conde is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Esther Conde has authored 51 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Pulmonary and Respiratory Medicine, 25 papers in Oncology and 18 papers in Cancer Research. Recurrent topics in Esther Conde's work include Lung Cancer Treatments and Mutations (30 papers), Cancer Genomics and Diagnostics (17 papers) and Lung Cancer Diagnosis and Treatment (11 papers). Esther Conde is often cited by papers focused on Lung Cancer Treatments and Mutations (30 papers), Cancer Genomics and Diagnostics (17 papers) and Lung Cancer Diagnosis and Treatment (11 papers). Esther Conde collaborates with scholars based in Spain, United States and United Kingdom. Esther Conde's co-authors include Fernando López‐Ríos, Bárbara Angulo, Ana Suárez‐Gauthier, Montse Sánchez‐Céspedes, Rebeca Martínez, Moying Tang, Manuel Hidalgo, Ignacio Durán, Francisco Vera-Badillo and Á. López Encuentra and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Oncogene.

In The Last Decade

Esther Conde

49 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Esther Conde Spain	22	947	641	582	488	182	51	1.5k
Xian Lu United States	20	1.3k 1.4×	642 1.0×	1.1k 1.9×	454 0.9×	52 0.3×	39	1.9k
Audrey Mansuet‐Lupo France	22	722 0.8×	462 0.7×	981 1.7×	321 0.7×	39 0.2×	64	1.8k
Kazumi Nishino Japan	25	1.6k 1.6×	661 1.0×	1.4k 2.3×	735 1.5×	49 0.3×	164	2.3k
Francisco Sánchez-Vega United States	20	756 0.8×	768 1.2×	778 1.3×	481 1.0×	38 0.2×	59	1.7k
Kunkun Sun China	16	491 0.5×	409 0.6×	402 0.7×	347 0.7×	43 0.2×	71	1.2k
Daniel H. Hovelson United States	22	534 0.6×	424 0.7×	448 0.8×	387 0.8×	56 0.3×	45	1.7k
Elizabeth Fabre France	22	583 0.6×	441 0.7×	725 1.2×	367 0.8×	27 0.1×	91	1.5k
Xiaoyan Zhou China	23	279 0.3×	785 1.2×	526 0.9×	463 0.9×	55 0.3×	95	1.6k
Paulo Antônio Silvestre de Faria Brazil	19	587 0.6×	714 1.1×	277 0.5×	149 0.3×	74 0.4×	58	1.3k
Seung Eun Lee South Korea	19	545 0.6×	310 0.5×	475 0.8×	239 0.5×	50 0.3×	46	1.0k

Countries citing papers authored by Esther Conde

Since Specialization

Citations

This map shows the geographic impact of Esther Conde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esther Conde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esther Conde more than expected).

Fields of papers citing papers by Esther Conde

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Esther Conde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esther Conde. The network helps show where Esther Conde may publish in the future.

Co-authorship network of co-authors of Esther Conde

This figure shows the co-authorship network connecting the top 25 collaborators of Esther Conde. A scholar is included among the top collaborators of Esther Conde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Esther Conde. Esther Conde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cabo, Horacio, Esther Conde, Susana Hernández, et al.. (2024). Clinical Utility of Combined Tissue and Plasma Next-Generation Sequencing in Patients With Advanced, Treatment-Naïve NSCLC. JTO Clinical and Research Reports. 6(3). 100778–100778.

Hernández, Susana, Esther Conde, Marta Alonso de la Varga, et al.. (2023). A narrative review of methods for the identification of ALK fusions in patients with non-small cell lung carcinoma. Translational Lung Cancer Research. 12(7). 1549–1562. 8 indexed citations

Mezquita, Laura, J. Corral, Manuel Cobo, et al.. (2023). The role of sex and gender in the diagnosis and treatment of lung cancer: the 6th ICAPEM Annual Symposium. Clinical & Translational Oncology. 26(2). 352–362. 1 indexed citations

Isla, Dolores, María D. Lozano, Luis Paz‐Ares, et al.. (2023). Nueva actualización de las recomendaciones para la determinación de biomarcadores predictivos en el carcinoma de pulmón no célula pequeña: Consenso Nacional de la Sociedad Española de Anatomía Patológica y de la Sociedad Española de Oncología Médica. Revista Española de Patología. 56(2). 97–112. 4 indexed citations

Isla, Dolores, María D. Lozano, Luis Paz‐Ares, et al.. (2022). New update to the guidelines on testing predictive biomarkers in non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology. Clinical & Translational Oncology. 25(5). 1252–1267. 23 indexed citations

Mielgo-Rubio, Xabier, M. Martín, Jordi Remón, et al.. (2021). Targeted Therapy Moves to Earlier Stages of Non-Small-Cell Lung Cancer: Emerging Evidence, Controversies and Future Challenges. Future Oncology. 17(30). 4011–4025. 16 indexed citations

Mielgo-Rubio, Xabier, Virginia Calvo, J. Luna, et al.. (2020). Immunotherapy Moves to the Early-Stage Setting in Non-Small Cell Lung Cancer: Emerging Evidence and the Role of Biomarkers. Cancers. 12(11). 3459–3459. 9 indexed citations

Conde, Esther, et al.. (2016). Profile of Ventana ALK (D5F3) companion diagnostic assay for non-small-cell lung carcinomas. Expert Review of Molecular Diagnostics. 16(6). 707–713. 37 indexed citations

Ruano‐Gallego, David, et al.. (2015). Primary Cutaneous Ewing Sarcoma: Report of a Case. Fetal and Pediatric Pathology. 34(5). 315–321. 5 indexed citations

10.

Conde, Esther, Elisa Izquierdo, Luis Paz‐Ares, et al.. (2013). Lung adenocarcinoma in the era of targeted therapies: histological classification, sample prioritization, and predictive biomarkers. Clinical & Translational Oncology. 15(7). 503–508. 24 indexed citations

11.

López‐Ríos, Fernando, Bárbara Angulo, Rebeca Martínez, et al.. (2013). Comparison of Testing Methods for the Detection of BRAF V600E Mutations in Malignant Melanoma: Pre-Approval Validation Study of the Companion Diagnostic Test for Vemurafenib. PLoS ONE. 8(1). e53733–e53733. 38 indexed citations

12.

Conde, Esther, et al.. (2013). Diplopia From Pleomorphic Lipoma of the Orbit With Lateral Rectus Muscle Involvement. Ophthalmic Plastic and Reconstructive Surgery. 29(2). e53–e55. 3 indexed citations

13.

Vera-Badillo, Francisco, Esther Conde, & Ignacio Durán. (2012). Chromophobe renal cell carcinoma: A review of an uncommon entity. International Journal of Urology. 19(10). 894–900. 76 indexed citations

14.

García-García, Elena, Carlos Gómez-Martín, Bárbara Angulo, et al.. (2011). Hybridization for human epidermal growth factor receptor 2 testing in gastric carcinoma: a comparison of fluorescence in-situ hybridization with a novel fully automated dual-colour silver in-situ hybridization method. Histopathology. 59(1). 8–17. 35 indexed citations

15.

Conde, Esther, Bárbara Angulo, Óscar Toldos, et al.. (2010). The Use of P63 Immunohistochemistry for the Identification of Squamous Cell Carcinoma of the Lung. PLoS ONE. 5(8). e12209–e12209. 50 indexed citations

16.

Angulo, Bárbara, Elena García-García, Rebeca Martínez, et al.. (2010). A Commercial Real-Time PCR Kit Provides Greater Sensitivity than Direct Sequencing to Detect KRAS Mutations. Journal of Molecular Diagnostics. 12(3). 292–299. 93 indexed citations

17.

González‐Billalabeitia, Enrique, Ricardo Hitt, J.M. Fernández Gómez, et al.. (2009). Pre-treatment serum lactate dehydrogenase level is an important prognostic factor in high-grade extremity osteosarcoma. Clinical & Translational Oncology. 11(7). 479–483. 19 indexed citations

18.

Suárez‐Gauthier, Ana, Fernando López‐Ríos, Pedro P. Medina, et al.. (2007). Expression signatures in lung cancer reveal a profile for EGFR ‐mutant tumours and identify selective PIK3CA overexpression by gene amplification. The Journal of Pathology. 214(3). 347–356. 86 indexed citations

19.

Carretero, Julián, Pedro P. Medina, Raquel Blanco, et al.. (2006). Dysfunctional AMPK activity, signalling through mTOR and survival in response to energetic stress in LKB1-deficient lung cancer. Oncogene. 26(11). 1616–1625. 117 indexed citations

20.

Delgado, Juan F., Esther Conde, Violeta Sánchez, et al.. (2005). Pulmonary Vascular Remodeling in Pulmonary Hypertension Due to Chronic Heart Failure. European Journal of Heart Failure. 7(6). 1011–1016. 207 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact